Data completeness
1/8 — Limited
Drug data last refreshed 21h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Sulfadiazine is a sulfonamide antibiotic available as an oral tablet used to treat bacterial infections, particularly toxoplasmosis and certain other parasitic and bacterial conditions. The drug works by inhibiting bacterial dihydropteroate synthase, disrupting folate synthesis and bacterial growth. It is a legacy antibiotic with established clinical use across multiple indications.
PRE_LAUNCH
Pre-launch status indicates a developing product with uncertain commercial trajectory; team size and hiring velocity will depend on regulatory approval timeline.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Started Jul 2000
600 enrolled
Toxoplasmosis
Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
100 enrolled
Toxoplasmosis, CerebralHIV Infections
Career Relevance
Sulfadiazine is at pre-launch stage with zero linked job postings, indicating limited immediate hiring. Career opportunities will accelerate post-approval, primarily in regulatory compliance, commercial launch, and field execution roles.
Regulatory Affairs Specialist
Worked on SULFADIAZINE at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.